An Evaluation of the Effect of Community-based Pharmacist Intervention on Patients With Chronic Pain

This is a prospective, pre post, pilot cohort study to be conducted in patients with chronic pain, which is defined as pain that lasts beyond 3 months. To accomplish the primary and secondary objectives of the study, three phrases will be designed and completed during three months

Study Overview

• Status: Completed
• Conditions: Chronic Pain
• Intervention / Treatment: Other: medication reviews, assessment, recommendations, education.

Detailed Description

This study will evaluate the effectiveness of community-based pharmacist interventions on the quality of life of patients with chronic pain as determined by self-reported pain levels using an established scoring system. Participating pharmacists will enroll chronic pain patients from their normal practice to receive a consultation, which consists of an assessment of their current pain, a medication review, and education about their condition. Based on the information provided by the patient, the pharmacist will prepare a care plan, contact the patient's prescriber, and, in conjunction with the prescriber, implement the plan to help relieve their pain. Follow-up assessments will be done after 2 weeks, and 3 months.

• Study Type: Interventional
• Enrollment (Actual): 19
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Canada
  • Ontario
    • Kitchener, Ontario, Canada, N2G4X6
      • The PharmaShoppe

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

1. Aged 18 or older
2. Baseline average pain intensity using Brief Pain Inventory is 6 or higher
3. Ambulatory and able to attend the intervention
4. Complaining of pain for 3 months or longer

Exclusion Criteria:

1. Patients with malignant or cancer pain
2. Patients who are unable to communicate in English
3. Non-ambulatory and unable to attend the intervention at the participating site
4. Unable to give informed consent.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Pharmacist intervention; Within the pharmacist intervention arm, pharmacists will do medication reviews, assessment, recommendations, education.	Other: medication reviews, assessment, recommendations, education.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pain intensity change	Pain intensity will be measured with Brief Pain Inventory pain intensity subscale, and will be measured 3 times in total	baseline, 2 weeks follow-up, 3 months follow-up

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pain interference	Pain interference will be measured with Brief Pain Inventory pain interference subscale, and will be measured 3 times in total	baseline, 2 weeks follow-up, 3 months follow-up
Quality of life change	quality of life will be measured using Short Form-36, and will be measured twice in total.	baseline, 3 months follow-up

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
patient adherence	Patient adherence will be measured using Morisky medication adherence scale-8, and will be measured at 2 weeks and 3 months follow-up.The Morisky medication adherence scale-8 will be used as supplementary data to further elucidate potential factors behind the observed outcomes.	2 weeks follow-up and 3 months follow-up

Collaborators and Investigators

• Sponsor: University of Waterloo
• Investigators: Study Director: Feng Chang, University of Waterloo

Study record dates

Study Major Dates

• Study Start: February 1, 2016
• Primary Completion (Actual): May 1, 2017
• Study Completion (Actual): May 1, 2017

Study Registration Dates

• First Submitted: May 10, 2016
• First Submitted That Met QC Criteria: March 15, 2017
• First Posted (Actual): March 22, 2017

Study Record Updates

• Last Update Posted (Actual): November 17, 2017
• Last Update Submitted That Met QC Criteria: November 15, 2017
• Last Verified: November 1, 2017

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pain; Neurologic Manifestations; Chronic Pain
• Other Study ID Numbers: 21092 (Other Identifier: City of Hope Medical Center)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO